Lataa...

Single-Dose Pharmacokinetics and Safety of Abacavir (1592U89), Zidovudine, and Lamivudine Administered Alone and in Combination in Adults with Human Immunodeficiency Virus Infection

Abacavir (1592U89), a nucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type-1 (HIV-1), has been evaluated for efficacy and safety in combination regimens with other nucleoside analogs, including zidovudine (ZDV) and lamivudine (3TC). To evaluate...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Wang, Laurene H., Chittick, Gregory E., McDowell, James A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 1999
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC89348/
https://ncbi.nlm.nih.gov/pubmed/10390227
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!